In liver fibrosis, the cannabinoid receptors CB1 and CB2 exhibit opposite roles: CB1 activation accentuates hepatic fibrosis progression whereas CB2 displays anti-fibrogenic and anti-inflammatory activities. The gene discussed is CNR1; the disease is Hepatic fibrosis.